All Opportunities

Confidential Project

Project Jacaranda

US FDA, TGA and EU GMP approved specialty pharmaceutical company seeking US$14M to expand into higher-margin sterile manufacturing capabilities.

Industry
Specialty Pharma / CDMO
Capital Sought
US$14.0M
2031E Revenue
US$40M
2031E EBITDA
US$21M
Project Jacaranda — Investment Teaser Open in New Tab Download

Loading the teaser… if it does not appear, use “Open in New Tab” or “Download” above.

Strictly confidential · Prepared by Intelligentzia Capital Management · Scroll within the frame to navigate pages

Discuss This Project

Explore Project Jacaranda

Contact our team to receive additional information under NDA.